These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31861748)

  • 21. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.
    Sanwald-Ducray P; Dow J
    Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia.
    Dehkordi KA; Chaleshtori MH; Sharifi M; Jalili A; Fathi F; Roshani D; Nikkhoo B; Hakhamaneshi MS; Sani MRM; Ganji-Arjenaki M
    Indian J Hematol Blood Transfus; 2017 Sep; 33(3):327-332. PubMed ID: 28824233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):603-11. PubMed ID: 15155551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal pharmacokinetics and interspecies scaling of Ro 25-6833 and related (lactamylvinyl)cephalosporins.
    Richter WF; Heizmann P; Meyer J; Starke V; Lave T
    J Pharm Sci; 1998 Apr; 87(4):496-500. PubMed ID: 9548904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4.
    Nedaeinia R; Sharifi M; Avan A; Kazemi M; Nabinejad A; Ferns GA; Ghayour-Mobarhan M; Salehi R
    Tumour Biol; 2017 Mar; 39(3):1010428317692261. PubMed ID: 28347230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides.
    Lima JF; Carvalho J; Pinto-Ribeiro I; Almeida C; Wengel J; Cerqueira L; Figueiredo C; Oliveira C; Azevedo NF
    BMC Mol Biol; 2018 Jun; 19(1):6. PubMed ID: 29879907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scaffolding along nucleic acid duplexes using 2'-amino-locked nucleic acids.
    Astakhova IK; Wengel J
    Acc Chem Res; 2014 Jun; 47(6):1768-77. PubMed ID: 24749544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced recognition of non-complementary hybridization by single-LNA-modified oligonucleotide probes.
    Piao X; Yan Y; Yan J; Guan Y
    Anal Bioanal Chem; 2009 Jul; 394(6):1637-43. PubMed ID: 19513703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locked nucleic acid antisense inhibitor targeting apolipoprotein C-III efficiently and preferentially removes triglyceride from large very low-density lipoprotein particles in murine plasma.
    Yamamoto T; Obika S; Nakatani M; Yasuhara H; Wada F; Shibata E; Shibata MA; Harada-Shiba M
    Eur J Pharmacol; 2014 Jan; 723():353-9. PubMed ID: 24269597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, hybridization characteristics, and fluorescence properties of oligonucleotides modified with nucleobase-functionalized locked nucleic acid adenosine and cytidine monomers.
    Kaura M; Kumar P; Hrdlicka PJ
    J Org Chem; 2014 Jul; 79(13):6256-68. PubMed ID: 24933409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphosphonate LNA: a locked nucleic acid with a methylphosphonate linkage.
    Lauritsen A; Dahl BM; Dahl O; Vester B; Wengel J
    Bioorg Med Chem Lett; 2003 Jan; 13(2):253-6. PubMed ID: 12482433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokinetics.
    Zou P; Zheng N; Yu Y; Yu S; Sun W; McEachem D; Yang Y; Yu LX; Wang S; Sun D
    J Pharm Pharm Sci; 2012; 15(2):265-80. PubMed ID: 22579006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo.
    Javanbakht H; Mueller H; Walther J; Zhou X; Lopez A; Pattupara T; Blaising J; Pedersen L; Albæk N; Jackerott M; Shi T; Ploix C; Driessen W; Persson R; Ravn J; Young JAT; Ottosen S
    Mol Ther Nucleic Acids; 2018 Jun; 11():441-454. PubMed ID: 29858079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.
    Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC
    J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Human Pharmacokinetics of Antibody-Drug Conjugates From Nonclinical Data.
    Li C; Zhang C; Deng R; Leipold D; Li D; Latifi B; Gao Y; Zhang C; Li Z; Miles D; Chen SC; Samineni D; Wang B; Agarwal P; Lu D; Prabhu S; Girish S; Kamath AV
    Clin Transl Sci; 2019 Sep; 12(5):534-544. PubMed ID: 31115997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Deoxypodophyllotoxin Disposition in Mouse, Rat, Monkey, and Dog by Physiologically Based Pharmacokinetic Model and the Extrapolation to Human.
    Chen Y; Zhao K; Liu F; Xie Q; Zhong Z; Miao M; Liu X; Liu L
    Front Pharmacol; 2016; 7():488. PubMed ID: 28018224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia.
    Larsen MS; Juul RV; Groth AV; Simonsson USH; Kristensen AT; Knudsen T; Agersø H; Kreilgaard M
    Eur J Pharm Sci; 2018 Mar; 115():196-203. PubMed ID: 29369801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.
    Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW
    BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis.
    Qi H; Fu J; Luan J; Jiao C; Cui X; Cao X; Zhang Y; Wang Y; Kopp JB; Pi J; Zhou H
    Biochem Biophys Res Commun; 2020 Feb; 522(3):618-625. PubMed ID: 31787235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.